IRIS UniCatt

Caldarola, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.934
AS - Asia 5.018
EU - Europa 3.902
SA - Sud America 926
AF - Africa 150
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.727
SG - Singapore 2.344
DE - Germania 1.152
CN - Cina 1.102
BR - Brasile 763
VN - Vietnam 534
IT - Italia 510
SE - Svezia 482
FR - Francia 444
UA - Ucraina 251
FI - Finlandia 237
GB - Regno Unito 219
IE - Irlanda 165
IN - India 144
BD - Bangladesh 143
JP - Giappone 142
HK - Hong Kong 134
ID - Indonesia 125
CA - Canada 104
RU - Federazione Russa 93
PL - Polonia 91
AR - Argentina 65
IQ - Iraq 63
TR - Turchia 53
MX - Messico 50
NL - Olanda 45
ES - Italia 43
KR - Corea 41
ZA - Sudafrica 35
AT - Austria 34
EG - Egitto 34
SA - Arabia Saudita 32
BE - Belgio 27
EC - Ecuador 27
CI - Costa d'Avorio 23
PK - Pakistan 20
MA - Marocco 19
VE - Venezuela 18
MY - Malesia 15
CZ - Repubblica Ceca 14
JO - Giordania 14
KE - Kenya 14
LT - Lituania 14
AE - Emirati Arabi Uniti 13
PE - Perù 13
PH - Filippine 13
RO - Romania 13
UZ - Uzbekistan 13
PT - Portogallo 12
CO - Colombia 11
AU - Australia 9
IR - Iran 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
PY - Paraguay 9
AL - Albania 8
CH - Svizzera 8
CL - Cile 8
HN - Honduras 8
JM - Giamaica 8
TN - Tunisia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
NP - Nepal 7
PA - Panama 7
KG - Kirghizistan 6
BO - Bolivia 5
DK - Danimarca 5
HR - Croazia 5
IL - Israele 5
UY - Uruguay 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
GR - Grecia 4
HU - Ungheria 4
NO - Norvegia 4
TW - Taiwan 4
CY - Cipro 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
GY - Guiana 2
LU - Lussemburgo 2
PR - Porto Rico 2
PS - Palestinian Territory 2
Totale 15.934
Salva come PNG Salva come JPEG
Città #
Singapore 1.217
Chandler 682
Ashburn 608
San Jose 603
Dallas 259
Beijing 207
Ho Chi Minh City 178
New York 173
Dublin 160
Jacksonville 150
Lauterbourg 147
Hefei 143
Los Angeles 140
San Mateo 133
Tokyo 128
Hanoi 127
Hong Kong 119
Helsinki 114
Jakarta 112
Rome 102
Frankfurt am Main 101
Munich 101
Milan 97
Nanjing 94
The Dalles 92
Wilmington 85
São Paulo 80
Ann Arbor 79
Boston 76
Houston 75
Woodbridge 67
Boardman 64
Dearborn 63
Bremen 57
St Louis 56
Paris 54
Santa Clara 54
Cattolica 48
Nürnberg 48
Moscow 46
Princeton 46
North Bergen 45
Kent 42
Lawrence 42
Kraków 41
London 38
Chicago 37
Council Bluffs 37
Lappeenranta 36
Seoul 36
Da Nang 35
Warsaw 34
Seattle 33
Turku 33
Nanchang 32
Redwood City 31
Rio de Janeiro 30
Shanghai 30
Brooklyn 29
Marseille 29
Atlanta 27
Buffalo 27
Nuremberg 27
Fairfield 26
Montreal 26
Denver 25
Toronto 25
Baghdad 24
Brussels 24
Curitiba 24
Abidjan 23
Düsseldorf 23
Poplar 23
Orem 22
Amsterdam 19
Detroit 19
Haiphong 19
Leawood 19
Phoenix 19
Vienna 19
Kunming 18
Stockholm 18
Brasília 17
Hebei 17
Hyderabad 17
Redmond 17
Jeddah 16
Johannesburg 16
Mexico City 16
Ankara 15
Tianjin 15
Chennai 14
Norwalk 14
Amman 13
Guangzhou 13
Mumbai 13
Shenyang 13
Belo Horizonte 12
Changsha 12
City of London 12
Totale 8.413
Salva come PNG Salva come JPEG
Nome #
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 292
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study 239
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. 232
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 209
Linear atrophoderma of Moulin 203
Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis 189
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 188
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 184
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 171
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis. 171
Exacerbation of pemphigus after influenza vaccination. 171
A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris? 166
Clinical and ultrasonographic profile of adalimumab-treated hidradenitis suppurativa patients: A real-life monocentric experience 166
Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment 165
Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study 163
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 159
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients 156
Management of recurrent cutaneous abscesses during therapy with infliximab 155
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 151
Circumscribed pityriasis rubra pilaris type IV 148
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study 148
Evaluation of Endothelial Dysfunction in Psoriatic Patients by Different Techniques 147
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports 144
IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses 143
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 142
TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients 141
Lichenoid reaction induced by adalimumab 140
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 139
Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study 139
Etanercept therapy for psoriasis in a patient with numerous comorbidities 135
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 135
development of pemphigus vulgaris in a patient with psoriasis treated with cyclosporine 132
Dyshidrosiform pemphigoid: a well-defined clinical entity? 131
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 130
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 130
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a “real-world”, mono-center experience 128
Psychopathology and eating disorders in patients with psoriasis 127
Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy 125
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients 124
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 124
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 124
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 124
Human leukocyte antigen-B*58:01 allele in a familial case of Stevens-Johnson syndrome induced by allopurinol 120
Clinico-dermoscopic features of alopecia areata in patients with psoriasis 120
The preclinical discovery and development of deucravacitinib for the treatment of psoriasis 116
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 116
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 116
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study 115
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature 114
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy 114
Ixekizumab exposure associated with myelitis: A case report and a literature review 114
Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series 113
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 113
Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations 112
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination 112
Biological agents targeting interleukin-13 for atopic dermatitis 112
Evaluation of Upadacitinib efficacy in the treatment of Atopic Dermatitis of sensitive areas 110
Lichen sclerosus of the glans simulating melanoma 110
Dermoscopy of cutaneous sarcoidosis. 108
Untreated Psoriasis Impairs Male Fertility: A Case-Control Study 108
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic 107
Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. 107
Role of personalized medication training in improving efficacy and adherence to a topical therapy 107
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) 105
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 105
Childhood trauma and resilience in psoriatic patients: A preliminary report. 104
Childhood trauma and resilience in psoriatic patients: A preliminary report 103
Living with chronic spontaneous urticaria in Italy: A narrative medicine project to improve the pathway of patient care 103
Psoriasis and polycystic ovary syndrome: A new link in different phenotypes 103
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 103
2-Year Experience with Risankizumab in the Treatment of Plaque Psoriasis in Lazio Region, Italy 102
Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis 102
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 101
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 101
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 101
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 99
Dermoscopy of melanocytic lesions in patients affected by oculocutaneous albinism: a case series 99
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 98
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 98
Line-field confocal optical coherence tomography in alopecia areata and histopathological correlation 97
Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab 96
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment 96
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study 96
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy 96
Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature 94
Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy 92
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study–IL PSO (Italian Landscape Psoriasis) 91
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 91
A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis 91
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 90
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER–study) 90
Dermoscopy of necrobiosis lipoidica and granuloma annulare 88
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region 87
Drug survival of methotrexate and predictor factors for discontinuation in psoriasis 87
Long-Term Real-World Safety Profile of Secukinumab Assessed Through a 9-Year Experience in Patients Affected by Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Results From a Multicentric Retrospective Study 87
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 86
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study 86
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies 86
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 86
Granuloma faciale: a case report on long-term treatment with topical tacrolimus and dermoscopic aspects 84
Totale 12.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022671 75 55 20 19 35 21 10 113 17 40 129 137
2022/20231.787 219 255 118 281 145 222 64 139 238 22 60 24
2023/2024990 41 237 42 136 30 125 57 45 16 36 121 104
2024/20252.496 59 60 179 67 183 169 71 117 392 213 571 415
2025/20267.517 927 196 589 903 1.227 381 1.309 385 491 541 299 269
2026/2027204 204 0 0 0 0 0 0 0 0 0 0 0
Totale 16.147